Stock SPRB SPRUCE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Spruce Biosciences, Inc.

Equities

SPRB

US85209E1091

Market Closed - Nasdaq
Other stock markets
 01:30:00 07/06/2024 am IST 		5-day change 1st Jan Change
0.674 USD -6.74% Intraday chart for Spruce Biosciences, Inc. -3.78% -77.00%
04/06 Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder CI
03/06 Spruce Biosciences, Inc. Presents Phase 2 POWER Study Results of Tildacerfont for Treatment of Polycystic Ovary Syndrome at ENDO 2024 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Spruce Biosciences Recognized as a Bay Area Best Place to Work
BU
Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)
BU
Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder
CI
Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
BU
Spruce Biosciences, Inc. Presents Phase 2 POWER Study Results of Tildacerfont for Treatment of Polycystic Ovary Syndrome at ENDO 2024
CI
Spruce Biosciences : ENDO 2024
PU
Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference
BU
Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
BU
Spruce Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
BU
Spruce Biosciences : Pediatric Endocrine Society 2024 Annual Meeting
PU
Spruce Biosciences : Failure to Satisfy Listing Rule - Form 8-K
PU
Spruce Biosciences to Participate in May Investor Conferences
BU
Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
BU
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
BU
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB
PR
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
BU
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB
PR
North American Morning Briefing : Inflation -2-
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SPRB Stock
  4. News Spruce Biosciences, Inc.